Molecular Data Inc. American Depositary Shares
MKD was delisted on the 6th of September, 2022.
0 hedge funds and large institutions have $0 invested in Molecular Data Inc. American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $305K → $0 (-$305K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$305K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| – | -$305K | -4,258 | Closed |
|
MKD Hedge Fund Activity: Q1 2020 in Review
0 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Molecular Data Inc. American Depositary Shares (MKD) for Q1 2020, worth a combined $0 — down 100% from $305K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MKD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, exiting entirely with an estimated $305K sold.
- 0 institutional investors held Molecular Data Inc. American Depositary Shares (MKD) as of Q1 2020, down from 1 in Q4 2019.
- Funds reported $0 of Molecular Data Inc. American Depositary Shares stock for Q1 2020, down 100% quarter-over-quarter.
- 0 funds opened new Molecular Data Inc. American Depositary Shares positions in Q1 2020 and 1 closed out, a net change of -1 holder.
- The largest Molecular Data Inc. American Depositary Shares seller in Q1 2020 was Citadel Advisors, an estimated $305K sold.
Based on aggregated 13F filings for Q1 2020.